Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amisulpride vs Haloperidol with Valproate for Bipolar I Mania
NCT00126009Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, randomised, open-label trial of amisulpride in bipolar I disorder (2 arms), sponsored by Sanofi. Primary endpoint: Percentage of responders and completion of 3-month treatment. Started May 2004; status: completed.
02
Drugs
amisulpride
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00126009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00126009.